Study On The Standardization Of Integrated Mongolian And Western Medicine Treatment In The Recovery Period Of Hosa Disease

Objective:The optimization scheme of the treatment technology of integrated Mongolian and western medicine in the recovery period was formulated to provide a scientific basis for the diagnosis and treatment guidelines of integrated Mongolian and Western medicine during the recovery period.Methods:From 2021-12-01 to 2022-12-12-31 to the 2nd Department of encephalopathy and neurorehabilitation Department of the Affiliated Hospital of Inner Mongolia Minzu University,180 patients were collected according to the inclusion criteria and exclusion criteria.They were numbered according to the order of the study at visit,and were randomly divided into 3 groups with 60 cases each with the help of random number table.All the three groups were treated with basic Western medicine(antiplatelet aggregation:aspirin 100 mg once orally once daily;atorvastatin calcium tablets 20 mg once daily for lipid-lowering drugs).Control group:basic treatment of western medicine(Mongolian medical care).Test group A:basic treatment of western medicine+3g warm water after breakfast,3g,13 decoction 3g decoction+13 taste pill 1.5g warm water before going to bed(Mongolian medical care).Test group B:basic treatment of western medicine+3g warm water after breakfast,13 taste pill 3g and Eheulan 13 decoction after lunch+13 warm water pill 1.5g before bed(Mongolian medical care)+medical acupuncture therapy and bloodletting therapy after lunch.The total course of treatment was 4 weeks.Observe and record the scores of disease syndrome,NIHSS scale,BI index,and modified Rankin scale for 0 weeks,4 weeks,60 days and 90 days.Finally,the data were processed statistically processed by SPSS 26.0.Results:1.Efficacy observation indicators:(1)related scale score(SA disease syndrome scale,NIHSS scale,BI index,modified Rankin score),and significant at 0 weeks,60 weeks,and 90 days of follow-up(P<0.01).(2)Comparing the relevant scale score(SA disease syndrome scale,NIHSS scale,modified Rankin score),the control group was higher than the test group A,statistically significant(P<0.05).The control group was higher than the test group B with significant(P<0.01).Group A was higher than group B,statistically significant(P<0.05).Comparison of BI index:The control group was lower than the test group A,statistically significant(P<0.05).The control group was lower than the test group B,and it was significant(P<0.01).Group A was lower than group B,statistically significant(P<0.05).2.Clinical efficacy evaluation:the overall effective rate of the control group was 71.0%;the overall effective rate of group A was 91.0%;the overall effective rate of group B was 95.0%;the statistically significant difference between the three groups showed by the chi-square test,X2 value=46.782,P=<0.01.In the evaluation,the overall response rate of the control group was 71.0%;the overall response rate of test group A was 86.0%;the overall response rate of test group B was 91.0%,and X2 value=11.078,P<0.01.3.Safety indicators:compare the physical and chemical indicators of 0 weeks of treatment in the three groups:blood routine,liver and kidney function,Hcy,TG,HDL-C and electrocardiogram were within the normal range with no significant changes.The TC and LDL-C index in the blood were significantly lower(P<0.01).Conclusion:1.Compared with the simple treatment of western medicine and Mongolian and Western medicine,the recovery of neurological function and the improvement of life quality of patients in the recovery period of fire disease.2.The treatment effect of Mongolian and western medicine in the recovery period is good,with no obvious side effects,safe and reliable.